Novel Protein-Tyrosine Kinase Gene (Hck) Preferentially Expressed in Cells of Hematopoietic Origin STEVEN F

Total Page:16

File Type:pdf, Size:1020Kb

Novel Protein-Tyrosine Kinase Gene (Hck) Preferentially Expressed in Cells of Hematopoietic Origin STEVEN F MOLECULAR AND CELLULAR BIOLOGY, June 1987, p. 2276-2285 Vol. 7, No. 6 0270-7306/87/062276-10$02.00/0 Copyright © 1987, American Society for Microbiology Novel Protein-Tyrosine Kinase Gene (hck) Preferentially Expressed in Cells of Hematopoietic Origin STEVEN F. ZIEGLER,"12 JAMEY D. MARTH,"', DAVID B. LEWIS,4 AND ROGER M. PERLMUTTER' 2,5* Howard Hughes Medical Institute' and the Departments ofBiochemistry,2 Medicine,s Pediatrics,4 and Pharmacology,3 University of Washington School of Medicine, Seattle, Washington 98195 Received 16 December 1986/Accepted 18 March 1987 Protein-tyrosine kinases are implicated in the control of cell growth by virtue of their frequent appearance as products of retroviral oncogenes and as components of growth factor receptors. Here we report the characterization of a novel human protein-tyrosine kinase gene (hck) that is primarily expressed in hematopoietic cells, particularly granulocytes. The hck gene encodes a 505-residue polypeptide that is closely related to pp56kk, a lymphocyte-specific protein-tyrosine kinase. The exon breakpoints of the hck gene, partially defined by using murine genomic clones, demonstrate that hck is a member of the src gene family and has been subjected to strong selection pressure during mammalian evolution. High-level expression of hck transcripts in granulocytes is especially provocative since these cells are terminally differentiated and typically survive in vivo for only a few hours. Thus the hck gene, like other members of the src gene family, appears to function primarily in cells with little growth potential. Specific phosphorylation of proteins on tyrosine residues line Ml induces monocytoid differentiation (18), presumably was first detected in lysates of cells infected with acutely as a result of activation of endogenous pp60csrc (7). transforming retroviruses and is now known to be mediated Additional evidence for the involvement of src-like pro- by two related but distinct classes of protein-tyrosine tein-tyrosine kinases in the control of differentiation has kinases (24). Members of the first class are integral mem- come from analysis of the Ick gene and its product, pp56lck. brane proteins and are, in many cases, receptors for cellular Expression of Ick is entirely restricted to lymphoid cells (34) growth factors. The receptors for epidermal growth factor and is inhibited by mitogen-induced activation of resting (15), platelet-derived growth factor (17), insulin, insulinlike cells (J. D. Marth, D. B. Lewis, C. B. Wilson, M. E. Gearn, growth factor 1 (52), and colony stimulating factor 1 (42, 45) E. G. Krebs, and R. M. Perlmutter, manuscript submitted). all exhibit ligand-stimulated protein-tyrosine kinase activity In a search for other members of the src gene family that and, along with the proteins encoded by the oncogenes neu exhibit lineage-restricted expression, we used a murine lck and trk, are members of this first group. probe to screen a cDNA library constructed by using mRNA The second class of protein-tyrosine kinases, exemplified from mitogen-stimulated human leukocytes. Here we report by the 60-kilodalton product of the c-src gene, includes the isolation and characterization of a novel protein-tyrosine molecules that are often membrane associated but lack an kinase gene, a member of the src gene family, that is extracellular domain (24). Although the function of these primarily expressed in normal circu ting granulocytes and molecules is in no case known, the majority were first to a much lesser extent in tonsillar B lymphocytes. The identified as cellular homologs of retroviral oncogenes, for high-level expression of hck (for hematopoietic cell kinase) example, c-src, c-fgr, and c-abl (5, 54). Thus, it is attractive in granulocytes, a population of short-lived terminally differ- to view all of the protein-tyrosine kinases, those that are entiated cells, again focuses attention on the potential role of integral membrane proteins as well as those that are simply members of the src gene family in regulating commitment membrane associated, as components of signal transduction within specific cell lineages. systems regulating cell proliferation. At the same time, several lines of evidence indicate that MATERIALS AND METHODS the membrane-associated protein-tyrosine kinases regulate Genomic and cDNA libraries and library screening. A aspects of differentiation in postmitotic cells. In vertebrate of (9, 31, 53), as well as invertebrate (47), development, c-src library mitogen-stimulated human peripheral leukocyte expression increases in committed neuronal cells that have cDNA in the bacteriophage vector Xgtl0 was the kind gift of little replicative potential. Similarly, maximal c-src expres- P. Concannon and L. Hood (12). A BALB/c mouse genomic sion is associated with terminal differentiation of human library was constructed by partial digestion of sperm DNA myeloid cells, and this increase can be modeled in with AluI and HaeIII and subsequent ligation into Charon promyelocytic leukemias induced to differentiate by physio- 4A bacteriophage arms as previously described (40). A logic stimuli (4, 18). In both of these systems, it is possible 1.7-kilobase (kb) EcoRI fragment representing the entire Ick that alterations in c-src expression actually promote the coding sequence (34) was isolated from the NT18 plasmid by acquisition of a differentiated phenotype. Thus, the introduc- gel electrophoresis and used as a probe. Hybridization was tion of src expression constructs into the PC12 pheochromo- carried out as previously described (40), and filters were cytoma induces neurite washed at 65°C in lx SSC (lx SSC is 0.15 M NaCl plus outgrowth (1), and expression of 0.015 M sodium citrate)-0.1% sodium dodecyl sulfate for 30 polyoma middle T antigen in the mouse myelomonocytic cell min before autoradiography. Isolation and fractionation of human peripheral blood cells. Mononuclear cells were isolated from adult peripheral blood * Corresponding author. by centrifugation on Ficoll-Paque (Pharmacia Fine Chemi- 2276 VOL. 7, 1987 STRUCTURE AND EXPRESSION OF THE hck GENE 2277 cals, Piscataway, N.J.) as described previously (57). T cells these, HK24, was therefore selected for more detailed were isolated by treatment of mononuclear cells with T-cell analysis. Lymphokwik (One Lambda, Los Angeles, Calif.). Over 98% Structure of HK24 cDNA. The HK24 clone contains a of the surviving cells were CD2 positive, and stimulation of 1,950-base-pair (bp) insert that encodes a protein-tyrosine interleukin-2 expression in these cells required both kinase closely related to, but distinct from, that encoded by concanavalin A and phorbol ester treatment, implying that Ick. Figure 1 presents a partial restriction map of this insert they were largely homogeneous T lymphocytes (29; data not and the complete nucleotide sequence deduced by the chain shown). Granulocytes were prepared by dextran sedimenta- termination method by using oligonucleotide primers (43). tion of whole blood followed by Ficoll-Paque centrifugation The first 73 nucleotides of the clone are derived from the 3' and hypotonic lysis of erythrocytes (20). These cells were untranslated region (residues 1778 to 1845) as a result of a greater than 99% reactive with a monoclonal antibody cloning artifact. The coding region sequence begins at posi- (1G10) specific for granulocytes (a gift of I. Bernstein, Fred tion 74. As shown in the accompanying paper by Quintrell et Hutchinson Cancer Research Center, Seattle, Wash.). al. (41), this represents the second base ofwhat is most likely Monocytes were isolated by using leukocyte fractions ob- the initiation codon within this transcript. If position 76 is tained from the Puget Sound Blood Bank. Cells were per- counted as the start of codon 2, the HK24 insert contains a mitted to adhere to polystyrene tissue culture flasks (Corning single long open reading frame encoding a 505-amino-acid Glass Works, Corning, N.Y.) for 2 h, vigorously washed, polypeptide, followed by a 335-bp 3' untranslated region and and removed by scraping (57). More than 90% of these cells a poly(A) tail. The consensus polyadenylation signal were viable, as judged by dye exclusion, and 89o were AAUAAA is located at position 1895. Overall, the HK24 nonspecific esterase positive (57). insert is 70% identical to the murine Ick sequence, and this CeHl lines. The murine T-cell line SL3 and the B-cell line homology is concentrated in a region between nucleotides WEHI 279.1 were obtained from Carol Sibley. The S107 256 and 1590 that includes the protein-tyrosine kinase cata- plasmacytoma was obtained from Matthew Scharff. The lytic domain. previously unpublished hybridoma cell line 4G11 was gener- Typical protein-tyrosine kinase encoded by HK24. The ously provided by Joan Klotz. All cells were propagated in 505-amino-acid sequence encoded by the HK24 cDNA de- RPMI supplemented with glutamine and 10% fetal calf serum fines a protein that is closely related to, but distinct from, all in a humidifed 5% CO2 environment. previously described protein-tyrosine kinases. In particular, RNA isolation and RNA blotting. Total RNA from mouse the HK24-encoded protein is most closely related to the or human tissues was obtained by homogenization in predicted products of the human lyn (58) and murine lck (34, guanidinium thiocyanate as previously described (11). 55) genes (70 and 64% amino acid identity, respectively). Poly(A)+ material was then isolated by chromatography on The deduced sequence of the HK24-encoded protein is oligo(dT)-cellulose (3). Subsequent electrophoresis in form- compared with the conceptual translations of murine lck, aldehyde-agarose gels, transfer to nitrocellulose, and hybrid- human c-lyn, and avian c-src in Fig. 2. Both pp6fi-src and ization were performed as previously described (51). pp56lck are myristylated at their amino termini (10, 32), and DNA sequencing. Relevant DNA fragments were isolated it is probable that this modification is also a feature of the from phage clones by digestion with restriction endonu- HK24- and lyn-encoded proteins, both of which share the cleases and were subcloned into M13mpl8 and M13mp19 for amino-terminal residues M-G-C in common with ppS6lck.
Recommended publications
  • Bayesian GWAS and Network Analysis Revealed New Candidate Genes for Number of Teats in Pigs
    J Appl Genetics DOI 10.1007/s13353-014-0240-y ANIMAL GENETICS • ORIGINAL PAPER Bayesian GWAS and network analysis revealed new candidate genes for number of teats in pigs L. L. Verardo & F. F. Silva & L. Varona & M. D. V. Resende & J. W. M. Bastiaansen & P. S. Lopes & S. E. F. Guimarães Received: 7 March 2014 /Revised: 27 May 2014 /Accepted: 23 July 2014 # Institute of Plant Genetics, Polish Academy of Sciences, Poznan 2014 Abstract The genetic improvement of reproductive traits comparisons based on deviance posterior distribution indicat- such as the number of teats is essential to the success of the ed the superiority of Gaussian model. In general, our results pig industry. As opposite to most SNP association studies that suggest the presence of 19 significant SNPs, which mapped consider continuous phenotypes under Gaussian assumptions, 13 genes. Besides, we predicted gene interactions through this trait is characterized as a discrete variable, which could networks that are consistent with the mammals known breast potentially follow other distributions, such as the Poisson. biology (e.g., development of prolactin receptor signaling, and Therefore, in order to access the complexity of a counting cell proliferation), captured known regulation binding sites, random regression considering all SNPs simultaneously as and provided candidate genes for that trait (e.g., TINAGL1 covariate under a GWAS modeling, the Bayesian inference and ICK). tools become necessary. Currently, another point that deserves to be highlighted in GWAS is the genetic dissection of com- Keywords Counting data . Genes . Reproductive traits . SNP plex phenotypes through candidate genes network derived association from significant SNPs.
    [Show full text]
  • Itk Tyrosine Kinase Substrate Docking Is Mediated by a Nonclassical SH2 Domain Surface of PLC␥1
    Itk tyrosine kinase substrate docking is mediated by a nonclassical SH2 domain surface of PLC␥1 Lie Min, Raji E. Joseph, D. Bruce Fulton, and Amy H. Andreotti1 Department of Biochemistry, Biophysics, and Molecular Biology, Iowa State University, Ames, IA 50011 Edited by Susan S. Taylor, University of California at San Diego, La Jolla, CA, and approved October 20, 2009 (received for review October 1, 2009) Interleukin-2 tyrosine kinase (Itk) is a Tec family tyrosine kinase that We have previously shown that the PLC␥1 SH2C domain mediates signaling processes after T cell receptor engagement. Acti- (spanning residues 659–756 within full-length PLC␥1) binds di- vation of Itk requires recruitment to the membrane via its pleckstrin rectly to the Itk kinase domain and is required for efficient homology domain, phosphorylation of Itk by the Src kinase, Lck, and phosphorylation of Y783 by Itk (26). Fragments of PLC␥1 that binding of Itk to the SLP-76/LAT adapter complex. After activation, Itk contain Y783 but not the SH2C domain are not efficiently phos- phosphorylates and activates phospholipase C-␥1 (PLC-␥1), leading to phorylated by Itk. Moreover, phosphorylation of PLC␥1 substrate production of two second messengers, DAG and IP3. We have previ- fragments that contain both SH2C and Y783 (spanning 659–789, ously shown that phosphorylation of PLC-␥1 by Itk requires a direct, hereafter referred to as PLC␥1 SH2C-linker) can be inhibited by phosphotyrosine-independent interaction between the Src homol- titration with isolated PLC␥1 SH2C domain (26). The excess, free ogy 2 (SH2) domain of PLC-␥1 and the kinase domain of Itk.
    [Show full text]
  • Src-Family Kinases Impact Prognosis and Targeted Therapy in Flt3-ITD+ Acute Myeloid Leukemia
    Src-Family Kinases Impact Prognosis and Targeted Therapy in Flt3-ITD+ Acute Myeloid Leukemia Title Page by Ravi K. Patel Bachelor of Science, University of Minnesota, 2013 Submitted to the Graduate Faculty of School of Medicine in partial fulfillment of the requirements for the degree of Doctor of Philosophy University of Pittsburgh 2019 Commi ttee Membership Pa UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE Commi ttee Membership Page This dissertation was presented by Ravi K. Patel It was defended on May 31, 2019 and approved by Qiming (Jane) Wang, Associate Professor Pharmacology and Chemical Biology Vaughn S. Cooper, Professor of Microbiology and Molecular Genetics Adrian Lee, Professor of Pharmacology and Chemical Biology Laura Stabile, Research Associate Professor of Pharmacology and Chemical Biology Thomas E. Smithgall, Dissertation Director, Professor and Chair of Microbiology and Molecular Genetics ii Copyright © by Ravi K. Patel 2019 iii Abstract Src-Family Kinases Play an Important Role in Flt3-ITD Acute Myeloid Leukemia Prognosis and Drug Efficacy Ravi K. Patel, PhD University of Pittsburgh, 2019 Abstract Acute myelogenous leukemia (AML) is a disease characterized by undifferentiated bone-marrow progenitor cells dominating the bone marrow. Currently the five-year survival rate for AML patients is 27.4 percent. Meanwhile the standard of care for most AML patients has not changed for nearly 50 years. We now know that AML is a genetically heterogeneous disease and therefore it is unlikely that all AML patients will respond to therapy the same way. Upregulation of protein-tyrosine kinase signaling pathways is one common feature of some AML tumors, offering opportunities for targeted therapy.
    [Show full text]
  • Several Galactosyltransferase Activities Are Associated with Mouse Chromosome 17
    Copyright 0 1986 by the Genetics Society of America SEVERAL GALACTOSYLTRANSFERASE ACTIVITIES ARE ASSOCIATED WITH MOUSE CHROMOSOME 17 KIYOSHI FURUKAWA,**' STEPHEN ROTH* AND JANET SAWICKI? *Department of Biology, University of Pennsylvania, and +Wistar Institute of Anatomy and Biology, Philadelphia, Pennsylvania 19104 Manuscript received May 20, 1986 Accepted July 24, 1986 ABSTRACT Indirect evidence suggests that some major histocompatibility complex (MHC) proteins are glycosyltransferases. No sequence or mapping information is avail- able for transferases, although ganglioside variations in mice are linked to the H-2 complex on chromosome 17, and one galactosyltransferase activity on mouse sperm varies with T/t complex genotypes, also on chromosome 17. In the present experiments, diploid and trisomy 17 mouse embryos were assayed for four dif- ferent galactosyltransferase activities. The same preparations were assayed for isocitrate dehydrogenase (ld-1, chromosome I) and glyoxalase-1 (Glo-1, chro- mosome 17). Galactosyltransferase specific activities in trisomy 17 embryos are almost 1.5 times higher than in diploid embryos. The correlation between gal- actosyltransferase activities and chromosome 17 dosage indicates that the struc- tural or regulatory gene for these enzymes are located on chromosome 17. LYCOSYLTRANSFERASES transfer sugars from activated donors to an G exceedingly wide variety of acceptors. Several lines of evidence suggest a relationship between glycosyltransferases and the products of the major his- tocompatibility complex (MHC) family of genes (ROTH 1985). First, like MHC products, some transferases have intercellular recognition functions (ROTH, MCGUIREand ROSEMAN197 1; SHUR 1982). Second, when carefully purified, glycosyltransferases appear to exist in structurally related groups (NAGAI, MUENSCHand YOSHIDA1976; NACAI et al. 1978a, b; FURUKAWAand ROTH 1985).
    [Show full text]
  • Inhibition of Src Family Kinases and Receptor Tyrosine Kinases by Dasatinib: Possible Combinations in Solid Tumors
    Published OnlineFirst June 13, 2011; DOI: 10.1158/1078-0432.CCR-10-2616 Clinical Cancer Molecular Pathways Research Inhibition of Src Family Kinases and Receptor Tyrosine Kinases by Dasatinib: Possible Combinations in Solid Tumors Juan Carlos Montero1, Samuel Seoane1, Alberto Ocaña2,3, and Atanasio Pandiella1 Abstract Dasatinib is a small molecule tyrosine kinase inhibitor that targets a wide variety of tyrosine kinases implicated in the pathophysiology of several neoplasias. Among the most sensitive dasatinib targets are ABL, the SRC family kinases (SRC, LCK, HCK, FYN, YES, FGR, BLK, LYN, and FRK), and the receptor tyrosine kinases c-KIT, platelet-derived growth factor receptor (PDGFR) a and b, discoidin domain receptor 1 (DDR1), c-FMS, and ephrin receptors. Dasatinib inhibits cell duplication, migration, and invasion, and it triggers apoptosis of tumoral cells. As a consequence, dasatinib reduces tumoral mass and decreases the metastatic dissemination of tumoral cells. Dasatinib also acts on the tumoral microenvironment, which is particularly important in the bone, where dasatinib inhibits osteoclastic activity and favors osteogenesis, exerting a bone-protecting effect. Several preclinical studies have shown that dasatinib potentiates the antitumoral action of various drugs used in the oncology clinic, paving the way for the initiation of clinical trials of dasatinib in combination with standard-of-care treatments for the therapy of various neoplasias. Trials using combinations of dasatinib with ErbB/HER receptor antagonists are being explored in breast, head and neck, and colorectal cancers. In hormone receptor–positive breast cancer, trials using combina- tions of dasatinib with antihormonal therapies are ongoing. Dasatinib combinations with chemother- apeutic agents are also under development in prostate cancer (dasatinib plus docetaxel), melanoma (dasatinib plus dacarbazine), and colorectal cancer (dasatinib plus oxaliplatin plus capecitabine).
    [Show full text]
  • Second Generation Inhibitors of BCR- ABL for the Treatment of Imatinib- Resistant Chronic Myeloid Leukaemia
    REVIEWS Second generation inhibitors of BCR- ABL for the treatment of imatinib- resistant chronic myeloid leukaemia Ellen Weisberg*, Paul W. Manley‡, Sandra W. Cowan-Jacob§, Andreas Hochhaus|| and James D. Griffin¶ Abstract | Imatinib, a small-molecule ABL kinase inhibitor, is a highly effective therapy for early-phase chronic myeloid leukaemia (CML), which has constitutively active ABL kinase activity owing to the expression of the BCR-ABL fusion protein. However, there is a high relapse rate among advanced- and blast-crisis-phase patients owing to the development of mutations in the ABL kinase domain that cause drug resistance. Several second-generation ABL kinase inhibitors have been or are being developed for the treatment of imatinib- resistant CML. Here, we describe the mechanism of action of imatinib in CML, the structural basis of imatinib resistance, and the potential of second-generation BCR-ABL inhibitors to circumvent resistance. The BCR-ABL oncogene, which is the product of the design of new drugs to circumvent resistance, and Philadelphia chromosome (Ph) 22q, encodes a chimeric several new agents have been developed specifically BCR-ABL protein that has constitutively activated ABL for this purpose. These compounds have been well tyrosine kinase activity; it is the underlying cause of characterized for efficacy against the mutant enzymes chronic myeloid leukaemia (CML)1–3. Whereas the 210 in preclinical studies, and impressive therapeutic activ- kDa BCR-ABL protein is expressed in patients with ity has now been reported for two second generation CML, a 190 kDa BCR-ABL protein, resulting from an drugs in phase I and II clinical trials in patients with *Dana Farber Cancer alternative breakpoint in the BCR gene, is expressed in imatinib-resistant CML.
    [Show full text]
  • Supplementary Table 1. in Vitro Side Effect Profiling Study for LDN/OSU-0212320. Neurotransmitter Related Steroids
    Supplementary Table 1. In vitro side effect profiling study for LDN/OSU-0212320. Percent Inhibition Receptor 10 µM Neurotransmitter Related Adenosine, Non-selective 7.29% Adrenergic, Alpha 1, Non-selective 24.98% Adrenergic, Alpha 2, Non-selective 27.18% Adrenergic, Beta, Non-selective -20.94% Dopamine Transporter 8.69% Dopamine, D1 (h) 8.48% Dopamine, D2s (h) 4.06% GABA A, Agonist Site -16.15% GABA A, BDZ, alpha 1 site 12.73% GABA-B 13.60% Glutamate, AMPA Site (Ionotropic) 12.06% Glutamate, Kainate Site (Ionotropic) -1.03% Glutamate, NMDA Agonist Site (Ionotropic) 0.12% Glutamate, NMDA, Glycine (Stry-insens Site) 9.84% (Ionotropic) Glycine, Strychnine-sensitive 0.99% Histamine, H1 -5.54% Histamine, H2 16.54% Histamine, H3 4.80% Melatonin, Non-selective -5.54% Muscarinic, M1 (hr) -1.88% Muscarinic, M2 (h) 0.82% Muscarinic, Non-selective, Central 29.04% Muscarinic, Non-selective, Peripheral 0.29% Nicotinic, Neuronal (-BnTx insensitive) 7.85% Norepinephrine Transporter 2.87% Opioid, Non-selective -0.09% Opioid, Orphanin, ORL1 (h) 11.55% Serotonin Transporter -3.02% Serotonin, Non-selective 26.33% Sigma, Non-Selective 10.19% Steroids Estrogen 11.16% 1 Percent Inhibition Receptor 10 µM Testosterone (cytosolic) (h) 12.50% Ion Channels Calcium Channel, Type L (Dihydropyridine Site) 43.18% Calcium Channel, Type N 4.15% Potassium Channel, ATP-Sensitive -4.05% Potassium Channel, Ca2+ Act., VI 17.80% Potassium Channel, I(Kr) (hERG) (h) -6.44% Sodium, Site 2 -0.39% Second Messengers Nitric Oxide, NOS (Neuronal-Binding) -17.09% Prostaglandins Leukotriene,
    [Show full text]
  • Antigen Receptor Signaling: Integration of Protein Tyrosine Kinase Functions
    Oncogene (1998) 17, 1353 ± 1364 1998 Stockton Press All rights reserved 0950 ± 9232/98 $12.00 http://www.stockton-press.co.uk/onc Antigen receptor signaling: integration of protein tyrosine kinase functions Idan Tamir1 and John C Cambier1 1Division of Basic Sciences, Department of Pediatrics, National Jewish Medical and Research Center, 1400 Jackson Street, Denver, Colorado 80206, USA Antigen receptors on T and B cells function to processing and presentation to T cells, and to transduce signals leading to a variety of biologic transduce signals that lead to multiple, often alter- responses minimally including antigen receptor editing, native responses. This receptor, termed the B cell apoptotic death, developmental progression, cell activa- antigen receptor (BCR), belongs to the family of tion, proliferation and survival. The response to antigen Multichain Immune Recognition Receptors (MIRR), depends upon antigen anity and valence, involvement which includes the T cell receptor (TCR) and receptors of coreceptors in signaling and dierentiative stage of for the Fc portions of IgG (FcgRI, FcgRIIA, FcgRIIC, the responding cell. The requirement that these FcgRIIIA) and IgE (FceRI). Common to this family of receptors integrate signals that drive an array of receptors is an oligomeric structure which uses dierent responses may explain their evolved structural complex- membrane-spanning subunits for the purpose of ity. Antigen receptors are composed of multiple subunits antigen/Ig recognition vs signal transduction. The compartmentalized to provide antigen recognition and BCR is comprised of a membrane-associated form of signal transduction function. In lieu of on-board immunoglobulin (mIg), noncovalently associated with enzymatic activity these receptors rely on associated a disul®de linked CD79a/CD79b heterodimer (Figure Protein Tyrosine Kinases (PTKs) for their signaling 1) (for review see Cambier, 1995a; Gold and function.
    [Show full text]
  • Protein Tyrosine Kinases: Their Roles and Their Targeting in Leukemia
    cancers Review Protein Tyrosine Kinases: Their Roles and Their Targeting in Leukemia Kalpana K. Bhanumathy 1,*, Amrutha Balagopal 1, Frederick S. Vizeacoumar 2 , Franco J. Vizeacoumar 1,3, Andrew Freywald 2 and Vincenzo Giambra 4,* 1 Division of Oncology, College of Medicine, University of Saskatchewan, Saskatoon, SK S7N 5E5, Canada; [email protected] (A.B.); [email protected] (F.J.V.) 2 Department of Pathology and Laboratory Medicine, College of Medicine, University of Saskatchewan, Saskatoon, SK S7N 5E5, Canada; [email protected] (F.S.V.); [email protected] (A.F.) 3 Cancer Research Department, Saskatchewan Cancer Agency, 107 Wiggins Road, Saskatoon, SK S7N 5E5, Canada 4 Institute for Stem Cell Biology, Regenerative Medicine and Innovative Therapies (ISBReMIT), Fondazione IRCCS Casa Sollievo della Sofferenza, 71013 San Giovanni Rotondo, FG, Italy * Correspondence: [email protected] (K.K.B.); [email protected] (V.G.); Tel.: +1-(306)-716-7456 (K.K.B.); +39-0882-416574 (V.G.) Simple Summary: Protein phosphorylation is a key regulatory mechanism that controls a wide variety of cellular responses. This process is catalysed by the members of the protein kinase su- perfamily that are classified into two main families based on their ability to phosphorylate either tyrosine or serine and threonine residues in their substrates. Massive research efforts have been invested in dissecting the functions of tyrosine kinases, revealing their importance in the initiation and progression of human malignancies. Based on these investigations, numerous tyrosine kinase inhibitors have been included in clinical protocols and proved to be effective in targeted therapies for various haematological malignancies.
    [Show full text]
  • Intestinal Cell Kinase, a Protein Associated with Endocrine-Cerebro-Osteodysplasia Syndrome, Is a Key Regulator of Cilia Length and Hedgehog Signaling
    Intestinal cell kinase, a protein associated with endocrine-cerebro-osteodysplasia syndrome, is a key regulator of cilia length and Hedgehog signaling Heejung Moona,1, Jieun Songa,1, Jeong-Oh Shinb, Hankyu Leea, Hong-Kyung Kimb, Jonathan T. Eggenschwillerc, Jinwoong Bokb,2, and Hyuk Wan Koa,2 aCollege of Pharmacy, Dongguk University-Seoul, Goyang, 410-820, Korea; bDepartment of Anatomy, BK21 Plus Project for Medical Science, Yonsei University College of Medicine, Seoul 120-752, Korea; and cDepartment of Genetics, University of Georgia, Athens, GA 30606 Edited by Kathryn V. Anderson, Sloan-Kettering Institute, New York, NY, and approved April 29, 2014 (received for review December 12, 2013) Endocrine-cerebro-osteodysplasia (ECO) syndrome is a recessive and MAPK/MAK/(MAK-related kinase)MRK-overlapping kinase genetic disorder associated with multiple congenital defects in (MOK) (4). All RCK family kinases are composed of an N-ter- endocrine, cerebral, and skeletal systems that is caused by a mis- minal catalytic domain with a TDY motif and variable lengths of sense mutation in the mitogen-activated protein kinase-like intestinal a C-terminal domain with unknown function. In a study of the cell kinase (ICK) gene. In algae and invertebrates, ICK homologs are function of RCK family kinases, MAK was found to negatively involved in flagellar formation and ciliogenesis, respectively. How- regulate cilia length in photoreceptor cells by phosphorylating ever, it is not clear whether this role of ICK is conserved in mammals retinitis pigmentosa 1 (5). In lower organisms, physiological roles and how a lack of functional ICK results in the characteristic pheno- of RCK family kinases are relatively well studied.
    [Show full text]
  • Src Protein-Tyrosine Kinase Structure, Mechanism, and Small Molecule Inhibitors
    Pharmacological Research 94 (2015) 9–25 Contents lists available at ScienceDirect Pharmacological Research j ournal homepage: www.elsevier.com/locate/yphrs Invited Review Src protein-tyrosine kinase structure, mechanism, and small molecule inhibitors ∗ Robert Roskoski Jr. Blue Ridge Institute for Medical Research, 3754 Brevard Road, Suite 116, Box 19, Horse Shoe, NC 28742-8814, United States a r t i c l e i n f o a b s t r a c t Article history: The physiological Src proto-oncogene is a protein-tyrosine kinase that plays key roles in cell growth, Received 26 January 2015 division, migration, and survival signaling pathways. From the N- to C-terminus, Src contains a unique Accepted 26 January 2015 domain, an SH3 domain, an SH2 domain, a protein-tyrosine kinase domain, and a regulatory tail. The Available online 3 February 2015 chief phosphorylation sites of human Src include an activating pTyr419 that results from phosphory- lation in the kinase domain by an adjacent Src molecule and an inhibitory pTyr530 in the regulatory This paper is dedicated to the memory of tail that results from phosphorylation by C-terminal Src kinase (Csk) or Chk (Csk homologous kinase). Prof. Donald F. Steiner (1930–2014) – advisor, mentor, and discoverer of The oncogenic Rous sarcoma viral protein lacks the equivalent of Tyr530 and is constitutively activated. proinsulin. Inactive Src is stabilized by SH2 and SH3 domains on the rear of the kinase domain where they form an immobilizing and inhibitory clamp. Protein kinases including Src contain hydrophobic regulatory and Chemical compounds studied in this article: catalytic spines and collateral shell residues that are required to assemble the active enzyme.
    [Show full text]
  • Structure, Regulation, Signaling, and Targeting of Abl Kinases in Cancer
    436 M MONOGRAPHS Genes & Cancer 3(5-6) 436 –446 © The Author(s) 2012 Reprints and permission: Structure, Regulation, Signaling, and sagepub.com/journalsPermissions.nav DOI: 10.1177/1947601912458584 Targeting of Abl Kinases in Cancer http://ganc.sagepub.com Oliver Hantschel Abstract Abl kinases are prototypic cytoplasmic tyrosine kinases and are involved in a variety of chromosomal aberrations in different cancers. This causes the expression of Abl fusion proteins, such as Bcr-Abl, that are constitutively activated and drivers of tumorigenesis. Over the past decades, biochemical and functional studies on the molecular mechanisms of Abl regulation have gone hand in hand with progression of our structural understanding of autoinhibited and active Abl conformations. In parallel, Abl oncoproteins have become prime molecular targets for cancer therapy, using adenosine triphosphate (ATP)–competitive kinase inhibitors, such as imatinib. Abl-targeting drugs serve as a paradigm for our understanding of kinase inhibitor action, specificity, and resistance development. In this review article, I will review the molecular mechanisms that are responsible for the regulation of Abl kinase activity and how oncogenic Abl fusions signal. Furthermore, past and ongoing efforts to target Abl oncoproteins using ATP-competitive and allosteric inhibitors, as well as future possibilities using combination therapy, will be discussed. Keywords: tyrosine kinase, Bcr-Abl, kinase inhibitor, kinase structure Structure and Regulation of Abl of Abl play key roles in mediating
    [Show full text]